"The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. It is the first pill of its kind to receive approval from the regulator, marking a new era for weight-loss drugs. Wegovy's Danish makers Novo Nordisk said the once-daily pill was a "convenient option" to the injectable and would provide the same weight loss as the shot."
"The Wegovy pill showed an average weight loss of 16.6% during Novo Nordisk's trials, the firm said on Monday. A third of around 1,300 participants experienced 20% or greater weight loss in the same trial, it added. The pill is expected to be launched in the US in early January 2026. "Patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection," said Mike Doustdar, the firm's chief executive."
The U.S. Food and Drug Administration approved a pill version of Wegovy, making it the first pill of its kind authorized by the regulator. Novo Nordisk described the once-daily oral formulation as a convenient option that would provide the same weight loss as the injectable. Clinical trials showed an average weight loss of 16.6%, with about one-third of roughly 1,300 participants losing 20% or more. The pill is expected to launch in the U.S. in early January 2026. The approval could boost Novo Nordisk's sales after a difficult year and comes amid intense competition from rivals such as Eli Lilly, with Novo Nordisk shares rising nearly 10% in after-hours trading following the announcement.
Read at www.bbc.com
Unable to calculate read time
Collection
[
|
...
]